李为民,李俭强,李悦

• 1: 哈尔滨医科大学附属第一医院心内科
• 2:哈尔滨医科大学附属第一医院心内科
• 3:哈尔滨医科大学附属第一医院心内科

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李为民,李俭强,李悦

参考文献(References)：

• [1]Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHAguide-lines for the management of patients with ST-elevation myocardial infarction;Areport of the American College of Cardiology/Amer-ican Heart Association Task Force on Practice Guidelines(Com-mittee to Revise the1999Guidelines for the Management of pa-tients with acute myocardial infarction).J Am Coll Cardiol,2004,44:E1-E211.
• [2]Keeley EC,Boura JA,Grines CL.Primary angioplasty versus in-travenous thrombolytic therapy for acute myocardial infarction:a quantitative review of23randomized trials.Lancet,2003,361:13-20.
• [3]Widimsky P,Groch L,Zelizko M,et al.Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocar-dial infarction presenting to a community hospital without a cathe-terization laboratory.The PRAGUE study.Eur Heart J,2000,21:823-831.
• [4]Widimsky P,Budesinsky T,Vorac D,et al.Long distancetransport for primary angioplasty vs immediate thrombolysis in a-cute myocardial infarction:final results of the randomized nation-al multicentre trial-PRAGUE-2.Eur Heart J,2003,24:94-104.
• [5]Smith SC Jr,Feldman TE,Hirshfeld JW Jr,et al.ACC/AHA/SCAI2005guideline update for percutaneous coronary interven-tion:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(ACC/AHA/SCAI Writing Committee to Update2001Guidelines for Percutaneous Coronary Intervention).Circulation,2006,113:e166-286.
• [6]Silber S,Albertsson P,Aviles FF,et al.Guidelines for percuta-neous coronary interventions.The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.Eur Heart J,2005,26:804-847.
• [7]Assessment of the Safety and Efficacy of a NewTreatment Strategy with Percutaneous Coronary Intervention(ASSENT-4PCI)in-vestigators.Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction(ASSENT-4PCI):randomised trial.Lan-cet,2006,367:569-578.
• [8]Schomig A,Mehilli J,Antoniucci D,et al.Mechanical reperfu-sion in patients with acute myocardial infarction presenting more than12hours from symptom onset:a randomized controlled trial.JAMA,2005,293:2865-2872.
• [9]Hochman FS,Lasmas GA,Buller CE,et al.Coronary interven-tion for persistent occlusion after myocardial infarction.N Engl J Med,2006,355:2395-2407.
• [10]Dzavik V,Buller CE,Lamas GA,et al.Randomized trial of per-cutaneous coronary intervention for subacute infarct-related coro-nary artery occlusion to achieve long-term patency and improve ventricular function:the Total Occlusion Study of Canada(TO-SCA)-2trial.Circulation,2006,114:2449-2457.
• [11]Boden WE,O'Rourke RA,Teo KK,et al.Optimal medical ther-apy with or without PCI for stable coronary disease.N Engl J Med,2007,356:1503-1516.
• [12]Wijeysundera HC,Vijayaraghavan R,Nallamothu BK,et al.Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolyt-ic Therapy for ST-Segment Myocardial Infarction.A Meta-Analy-sis of Randomized Trials.J Am Coll Cardiol,2007,49:422-430.
• [13]Hochman JS,Sleeper LA,Webb JG,et al.Early revasculariza-tion and long-term survival in cardiogenic shock complicating a-cute myocardial infarction.JAMA,2006,295:2511-2515.
• [14]Spaulding C,Henry P,Teiger E,et al.Sirolimus-eluting versus uncoated stents in acute myocardial infarction.N Engl J Med,2006,355:1093-1104.
• [15]Laarman GJ,Suttorp MJ,Dirksen MT,et al.Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary interven-tion.N Engl J Med,2006,355:1105-1113.
• [16]Limbruno U,De Caterina R.EMERALD,AIMI,and PROM-ISE:is there still a potential for embolic protection in primary PCI?Eur Heart J,2006,27:1139-1145.
• [17]Silva-Orrego P,Colombo P,Bigi R,et al.Thrombus aspiration before primary angioplasty improves myocardial reperfusion in a-cute myocardial infarction:the DEAR-MI(Dethrombosis to En-hance Acute Reperfusion in Myocardial Infarction)study.J Am Coll Cardiol,2006,48:1552-1559.
• [18]Chen ZM,Jiang LX,Chen YP,et al.Addition of clopidogrel to aspirin in45,852patients with acute myocardial infarction:ran-domised placebo-controlled trial.Lancet,2005,366:1607-1621.
• [19]Sabatine MS,Cannon CP,Gibson CM,et al.Addition of clopi-dogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.N Engl J Med,2005,352:1179-1189.
• [20]Giraldez RR,Nicolau JC,Corbalan R,et al.Enoxaparin is su-perior to unfractionated heparin in patients with STelevation myo-cardial infarction undergoing fibrinolysis regardless of the choice of lytic:an ExTRACT-TIMI25analysis.Eur Heart J,2007,28:1566-1573.
• [21]Stone GW,White HD,Ohman EM,et al.Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention:a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy(ACUITY)trial.Lancet,2007,369:907-919.
• [22]Bates ER.New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocar-dial infarction.Curr Cardiol Rep,2007,9:289-297.
• [23]Collins SD,Baffour R,Waksman R.Cell therapy in myocardial infarction.Cardiovasc Revasc Med,2007,8:43-51.